![Michal Roytman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michal Roytman
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Michal Roytman
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michal Roytman
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The Hebrew University of Jerusalem | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
OMRIX Biopharmaceuticals, Inc.
![]() OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Chairman Founder | |
INTERPACE BIOSCIENCES, INC. | Medical Specialties | Chief Executive Officer | |
HighCape Partners Management LLC
![]() HighCape Partners Management LLC Investment ManagersFinance HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut.. | Investment Managers | Consultant / Advisor | |
Man & Science NV
![]() Man & Science NV Pharmaceuticals: MajorHealth Technology Man & Science NV is a Belgian medical device company that develops a novel, minimally invasive, battery-free neurostimulation system to reduce the pain and frequency of severe headache attacks. The company is based in Mont-Saint-Guibert, Belgium, and has subsidiaries in Norway. The company's therapies allow headache patients to return to a normal, pain-free life. The company's team consists of experienced scientists, engineers, clinical research specialists, business experts, and successful start-up founders and entrepreneurs. The company was founded in 2011 by Robert Taub, and Fabian Suarez Gonzalez has been the CEO of the company since 2022. | Pharmaceuticals: Major | Founder | |
Robelga SRL
![]() Robelga SRL Miscellaneous Commercial ServicesCommercial Services Robelga SRL provides business and management advisory services. The private company is based in Uccle, Belgium. The Belgian company was founded in 2008. The CEO is Robert Taub. | Miscellaneous Commercial Services | Chief Executive Officer | |
Herpain Urbis Retail Holding SA
![]() Herpain Urbis Retail Holding SA Financial ConglomeratesFinance Herpain Urbis Retail Holding SA is an investment holding Belgian company. The private company is based in Uccle, Belgium. The company was founded in 2015. Yvan Neirinckx has been the CEO of the company since 2015. | Financial Conglomerates | Director/Board Member | |
Novozymatic SA | Director/Board Member | ||
Nivelles Service Center SA | Director/Board Member | ||
Axis Gate SA | Director/Board Member | ||
Nivaxis Gate SA | Director/Board Member | ||
HighCape Capital Acquisition Corp. II
![]() HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Director/Board Member | |
Pig For Life SA
![]() Pig For Life SA Agricultural Commodities/MillingProcess Industries Pig For Life SA is a Belgian company that specializes in breeding pigs. The company is based in Marche-en-Famenne, Belgium. | Agricultural Commodities/Milling | Director/Board Member | |
Harlan Biotech Israel Ltd. | Chief Tech/Sci/R&D Officer | ||
Insight Biopharmaceuticals Ltd.
![]() Insight Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Insight Biopharmaceuticals Ltd. is an Israeli company that manufactures and commercializes biosimilars and new antibody therapeutics. The private company is based in Rehovot, Israel. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ben-Gurion University of the Negev | College/University | Doctorate Degree | |
OWC PHARMACEUTICAL RESEARCH CORP. | Miscellaneous | Chief Tech/Sci/R&D Officer | |
NEUROSENSE THERAPEUTICS LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Lehigh University | College/University | Undergraduate Degree | |
University of Connecticut | College/University | Masters Business Admin | |
CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
University of Haifa | College/University | Graduate Degree | |
Teva Pharmaceuticals Ltd.
![]() Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AYA GOLD & SILVER INC. | Precious Metals | Chairman | |
LifeBond Ltd.
![]() LifeBond Ltd. Medical SpecialtiesHealth Technology LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel. | Medical Specialties | Director/Board Member | |
PDI, Inc.
![]() PDI, Inc. Commercial Printing/FormsCommercial Services PDI, Inc. provides format printing services. It specializes in document management, electronic pre-media and on-site prepress management, to offset and full-color variable digital print, bindery, multimedia and internet services. The company was founded in February 2007 and is headquartered in Kirkland, Canada. | Commercial Printing/Forms | Chief Executive Officer | |
Healthcare Ventures Associates, Inc.
![]() Healthcare Ventures Associates, Inc. Investment ManagersFinance Healthcare Ventures Associates, Inc. operates as a life science venture capital firm. The company is headquartered in Livingston, NJ. | Investment Managers | Founder | |
Wyeth Holdings LLC
![]() Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Chemicals: Agricultural | Corporate Officer/Principal | |
W. R. GRACE & CO. | Chemicals: Major Diversified | Chief Executive Officer | |
The Jewish Children's Museum | Director/Board Member | ||
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member | |
CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Chairman | |
W.R. Grace & Co. /Agracetus Transgenic Plant Division/ | Food: Major Diversified | Chief Executive Officer | |
TransPharma Medical Ltd.
![]() TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Pharmaceuticals: Major | Director/Board Member | |
Columbia College (New York) | College/University | Undergraduate Degree | |
Fu Foundation School of Engineering & Applied Science | College/University | Undergraduate Degree | |
Orphan Technologies Ltd.
![]() Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
INSEAD | College/University | Masters Business Admin | |
University of Antwerp | College/University | Undergraduate Degree | |
MONSANTO | Wholesale Distributors | Corporate Officer/Principal | |
Octapharma AG
![]() Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Pharmaceuticals: Major | Founder | |
Recoly NV
![]() Recoly NV Miscellaneous Commercial ServicesCommercial Services Recoly NV operates as a biotech company focusing on the discovery, development and commercialization of drug enhancing technologies that are used to create bio-better drugs. Its pipeline includes multiple products; all based on their proprietary technologies, in different development stages from marketing authorization filing through pivotal to pre-clinical studies. The company was founded by Robert Taub in 1992 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Founder | |
Revlon Healthcare | Corporate Officer/Principal | ||
NYXOAH SA | Medical Specialties | Founder |
Statistik
International
Vereinigte Staaten | 20 |
Belgien | 13 |
Israel | 12 |
Vereinigtes Königreich | 3 |
Kanada | 3 |
Sektoral
Health Technology | 17 |
Consumer Services | 10 |
Finance | 6 |
Commercial Services | 5 |
Process Industries | 4 |
Operativ
Director/Board Member | 23 |
Corporate Officer/Principal | 12 |
Chief Executive Officer | 7 |
Chairman | 7 |
Founder | 6 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Robert Taub | 27 |
Larry Ellberger | 16 |
Oron Yacoby-Zeevi | 7 |
Andrew Udell | 4 |
Tami Yardeni | 3 |
Ziva Mesika | 3 |
Elana Gazal | 3 |
Mikio Himizu | 1 |
- Börse
- Insiders
- Michal Roytman
- Unternehmensverbindungen